Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia-Reference-Cited by-同舟云学术

Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia

Published:2023-09-21 Issue:13 Volume:64 Page:2113-2122
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Li Li¹,Zhang Ran¹,Cao Weijie¹,Bian Zhilei¹,Qin Yang¹,Guo Rong¹,Zhang Suping¹,Peng Yingnan¹,Wan Dingming¹,Ma Wang²

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Funder

National Natural Science Foundation of China

Key Scientific Research Project of Henan University

Joint Co-construction Project of Henan Medical Technology Research Plan

Key Science and Technology Project of Henan Province

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2252948

Reference39 articles.

1. Hematopoietic stem cell transplantation for patients with AML in first complete remission

2. Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

3. Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

4. Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

5. Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse